EDESA BIOTECH, INC.
Profile
Company Names
EDESA BIOTECH, INC.
STELLAR BIOTECHNOLOGIES, INC.
Addresses
100 SPY COURT, MARKHAM, A6 L3R 5H6
332 EAST SCOTT STREET, PORT HUENEME, CA 93041
332 EAST SCOTT STREET, PORT HUNEMENE, CA 93041
Phone Numbers
289-800-9600
(805) 488-2800
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2007
State Incorporated:
BRITISH COLUMBIA, CANADA
Total Amount Raised:
$40,374,082.00
Number of Funding Rounds:
8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2026-06-16
$3,499,986.00
$3,500,000.00
$14.00
Equity
7
2025-02-12
$15,000,000.00
$15,000,000.00
$0.00
Equity
6
2022-03-21
$0.00
INDEFINITE
INDEFINITE
5
2016-07-06
$6,750,000.00
$6,750,000.00
$0.00
4
2013-09-09
$12,000,000.00
$12,000,000.00
$0.00
Equity
3
2013-04-03
$1,613,700.00
$1,613,700.00
$0.00
Equity
2
2013-01-02
$504,596.00
$505,000.00
$404.00
Equity
1
2012-10-25
$1,005,800.00
$1,005,800.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL
BROOKS
EXECUTIVE OFFICER
DARRELL
BROOKSTEIN
EXECUTIVE OFFICER, DIRECTOR
SCOTT
DAVIS
EXECUTIVE OFFICER
BAILARD LONG/SHORT OFFSHORE FUND, LTD
| GREEN PLANET HOLDINGS, INC.
| CLEARVIEW INTERNATIONAL, LLC
| BAILARD LONG/SHORT OFFSHORE FUND, LTD.
| WEBB-MASON, INC.
| TERRACE ENERGY CORP
| STELLAR BIOTECHNOLOGIES, INC.
| ECPM HOLDINGS, LLC
| DFM GROUP, INC.
| ENCORE ENERGY CORP.
| TRUE SYNC MEDIA, INC.
| GLOBEX DATA LTD.
| EAST ASIA MINERALS CORP
| DESERT MOUNTAIN ENERGY CORP.
| C2C GOLD CORP.
| RAINDROP VENTURES INC.
| IMETAL RESOURCES INC.
| TUDOR GOLD CORP.
| HIGHWAY 50 GOLD CORP.
| VESCENT TECHNOLOGIES, INC.
| C2C METALS CORP.
| NATIONS ROYALTY CORP.
| TORRENT GOLD INC.
| URANO ENERGY CORP.
| VERDERA ENERGY CORP.
| FORGE RESOURCES CORP.
| GOLDSTORM METALS CORP.
| DLP RESOURCES INC.
| GROUP 11 TECHNOLOGIES INC.
| VERDERA ENERGY CORP.
| MANHATTAN METALS CORP.
DAVID
LIU
DIRECTOR
FRANK
R.
OAKES
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-06-16
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-02-12
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-09-09
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-04-03
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-01-02
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-10-25

